Header cover image

Software Healthcare Sector

Results

2168

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2168 companies

Atomo Diagnostics

Market Cap: AU$15.3m

Engages in the development and sale of medical devices worldwide.

AT1

AU$0.017

7D

-5.6%

1Y

-5.6%

Aspire Biopharma Holdings

Market Cap: US$11.0m

An early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States.

ASBP

US$8.27

7D

8.2%

1Y

-98.7%

LexaGene Holdings

Market Cap: CA$14.8m

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.

LXG.H

CA$0.10

7D

0%

1Y

-43.2%

Quoin Pharmaceuticals

Market Cap: US$10.9m

A late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

QNRX

US$5.07

7D

2.0%

1Y

-31.3%

Vistagen Therapeutics

Market Cap: US$10.8m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

VTGN

US$0.25

7D

2.6%

1Y

-92.0%

Theriva Biologics

Market Cap: US$10.8m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

TOVX

US$0.24

7D

5.3%

1Y

-43.4%

HeartSciences

Market Cap: US$10.8m

A medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence.

HSCS

US$3.00

7D

40.8%

1Y

-13.0%

Ceryvyn Therapeutics

Market Cap: AU$15.0m

A clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States.

CYV

AU$0.011

7D

0%

1Y

n/a

Hemostemix

Market Cap: CA$14.8m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

HEM

CA$0.07

7D

-6.7%

1Y

-12.5%

ALR Technologies SG

Market Cap: US$10.7m

A data management company, provides diabetes care management solutions.

ALRT.F

US$0.017

7D

-10.5%

1Y

78.9%

Aurora Spine

Market Cap: CA$14.7m

Through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada.

ASG

CA$0.19

7D

-13.6%

1Y

-36.7%

Bullfrog AI Holdings

Market Cap: US$10.4m

Operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

BFRG

US$0.58

7D

9.0%

1Y

-53.6%

Non-Invasive Monitoring Systems

Market Cap: US$10.3m

Does not have significant operations.

NIMU.D

US$10.00

7D

8.0%

1Y

1,349.3%

Red White & Bloom Brands

Market Cap: CA$14.1m

Manufactures and distributes cannabis products and accessories in the United States, Canada, and internationally.

RWB

CA$0.03

7D

0%

1Y

n/a

Sintx Technologies

Market Cap: US$10.2m

An advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.

SINT

US$1.56

7D

-3.7%

1Y

-59.0%

United Health Products

Market Cap: US$10.2m

Develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States.

UEEC

US$0.037

7D

-10.8%

1Y

-59.4%

Aprea Therapeutics

Market Cap: US$10.1m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

APRE

US$0.95

7D

41.4%

1Y

-39.9%

MetaVia

Market Cap: US$10.1m

A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.

MTVA

US$1.64

7D

10.1%

1Y

-76.3%

Lotus Pharmaceuticals

Market Cap: US$10.0m

Does not have significant operations.

LTUS

US$0.0032

7D

-15.8%

1Y

-64.6%

AEON Biopharma

Market Cap: US$9.8m

A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.

AEON

US$0.21

7D

-13.5%

1Y

-72.0%

CONNEQT Health

Market Cap: AU$13.6m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

CQT

AU$0.015

7D

-11.8%

1Y

-46.4%

Medicure

Market Cap: CA$13.4m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

MPH

CA$1.30

7D

0%

1Y

13.0%

Lunai Bioworks

Market Cap: US$9.7m

A pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands.

LNAI

US$2.20

7D

1.6%

1Y

-88.1%

Lucyd

Market Cap: US$9.6m

Develops and sells smart eyewear in North America.

LUCY

US$1.07

7D

50.5%

1Y

-45.7%

Greenway Greenhouse Cannabis

Market Cap: CA$13.3m

Engages in the cultivation, processing, sale, bulk package, and wholesale of dry bud cannabis.

GWAY

CA$0.10

7D

11.1%

1Y

-50.0%

TruScreen Group

Market Cap: NZ$16.1m

Develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/North Africa.

TRU

NZ$0.015

7D

0%

1Y

-11.8%

Skye Bioscience

Market Cap: US$9.6m

A clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related metabolic diseases.

SKYE

US$2.02

7D

-29.8%

1Y

-93.0%

Scientific Industries

Market Cap: US$9.5m

Engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally.

SCND

US$0.80

7D

14.7%

1Y

9.8%

American Shared Hospital Services

Market Cap: US$9.5m

Provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.

AMS

US$1.47

7D

-2.6%

1Y

-40.7%

ReNerve

Market Cap: AU$13.3m

A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.

RNV

AU$0.077

7D

0%

1Y

-23.0%

Rapid Dose Therapeutics

Market Cap: CA$13.0m

A life sciences company, provides drug delivery technologies in Canada.

DOSE

CA$0.11

7D

10.0%

1Y

-37.1%

GENinCode

Market Cap: UK£6.8m

Engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient’s health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally.

GENI

UK£0.009

7D

0%

1Y

-35.7%

Cardiogeni

Market Cap: UK£6.7m

A clinical stage biotechnology company, develops heart failure medicines.

CGNI

UK£0.07

7D

0%

1Y

-6.7%

CompuMed

Market Cap: US$9.2m

Provides diagnostic telemedicine solutions in the United States.

CMPD

US$6.86

7D

1.6%

1Y

44.7%

Seegnal

Market Cap: CA$12.7m

Provides SaaS clinical division support solutions.

SEGN

CA$0.28

7D

0%

1Y

n/a

PharmaCielo

Market Cap: CA$12.7m

Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.

PCLO

CA$0.06

7D

9.1%

1Y

n/a

Page 36 of 61